Teva Can't Escape Suit Over Price-Hike Statements: Investors
A proposed class of Teva Pharmaceutical Industries Ltd. shareholders urged a Connecticut federal court Monday to keep alive their allegations that the Israeli drugmaker falsely indicated that profit growth was driven...To view the full article, register now.
Already a subscriber? Click here to view full article